Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Swedish authorities…
This article was written by Follow Rida Morwa is a former investment and commercial Banker, with over 35 years of experience. He…
By Paolo Pizzoli, Senior Economist, Italy, Greece Consumers regain confidence After a clear drop in November, Italian consumer confidence rebounded in December,…
Medical Properties Trust: An Odd Dividend Hike Against Heavy Debt Burden (NYSE:MPW)
By Press Room
1 Mins read
This article was written by Follow The equity market is a powerful mechanism as daily fluctuations in price get aggregated to incredible…
Crocs' Swing Trade Potential Emerges - Recovery/Tariff Risks Remain (NASDAQ:CROX)
By Press Room
1 Mins read
This article was written by Follow I am a full-time analyst interested in a wide range of stocks. With my unique insights…
This article was written by Follow My primary area of concentration will be on identifying companies of exceptional caliber, with a proven…
At Touchstone Investments, we recognize that not all mutual fund companies are created equal. Our commitment to being Distinctively Active means the…
Seapeak: Maintaining Preferred Stock Position Despite Russia Sanctions (NYSE:SEAL.PR.A)
By Press Room
1 Mins read
This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon….
This article was written by Follow Rida Morwa is a former investment and commercial Banker, with over 35 years of experience. He…
Apellis Pharmaceuticals: A Good Product That Just Misses The Mark (NASDAQ:APLS)
By Press Room
1 Mins read
This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over…